Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Finberg

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Immunological Investigations|November 1, 1994
A 21-mer synthetic peptide of toxic shock syndrome toxin 1, TSST-1[58-78], activates T cells by binding to MHC class II and by an MHC unrestricted xenostimulatory pathwayA Haregewoin, C Edwin, R C Hom, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1978
Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cellsR Finberg, S J Burakoff, H Cantor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1983
Effect of vesicular stomatitis virus (VSV) infection on the development and regulation of T cell-mediated immune responsesM S Sy, M Tsurufuji, R Finberg, et al.
International Immunology|February 7, 2001
Decreased immediate inflammatory gene induction in activating transcription factor-2 mutant miceA M Reimold, J Kim, R Finberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1979
The cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. II. Evidence for antigen-specific suppressor T cellsR Finberg, S J Burakoff, B Benacerraf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction ruleJ A Talcott, R D Siegel, R Finberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1979
The cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. I. Evidence for antigen-specific helper T cellsR Finberg, M I Greene, B Benacerraf, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1982
CT hybridomas: tumor cells capable of lysing virally infected target cellsR B Whitaker, R S Kauffman, M Che, et al.
Archives of Internal Medicine|December 1, 1988
The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentationJ A Talcott, R Finberg, R J Mayer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1984
Interaction of reovirus with cell surface receptors. IV. The reovirus type 3 receptor is expressed predominantly on murine Lyt-2,3+ and human T8+ cellsR L Epstein, R Finberg, M L Powers, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Immunological Investigations|November 1, 1994
A 21-mer synthetic peptide of toxic shock syndrome toxin 1, TSST-1[58-78], activates T cells by binding to MHC class II and by an MHC unrestricted xenostimulatory pathwayA Haregewoin, C Edwin, R C Hom, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1978
Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cellsR Finberg, S J Burakoff, H Cantor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1983
Effect of vesicular stomatitis virus (VSV) infection on the development and regulation of T cell-mediated immune responsesM S Sy, M Tsurufuji, R Finberg, et al.
International Immunology|February 7, 2001
Decreased immediate inflammatory gene induction in activating transcription factor-2 mutant miceA M Reimold, J Kim, R Finberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1979
The cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. II. Evidence for antigen-specific suppressor T cellsR Finberg, S J Burakoff, B Benacerraf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction ruleJ A Talcott, R D Siegel, R Finberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1979
The cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. I. Evidence for antigen-specific helper T cellsR Finberg, M I Greene, B Benacerraf, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1982
CT hybridomas: tumor cells capable of lysing virally infected target cellsR B Whitaker, R S Kauffman, M Che, et al.
Archives of Internal Medicine|December 1, 1988
The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentationJ A Talcott, R Finberg, R J Mayer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1984
Interaction of reovirus with cell surface receptors. IV. The reovirus type 3 receptor is expressed predominantly on murine Lyt-2,3+ and human T8+ cellsR L Epstein, R Finberg, M L Powers, et al.
Pageof 6